摘要
目的:观察冠心丹参滴丸对急性冠脉综合征(ACS)合并2型糖尿病(T2DM)病人经皮冠状动脉介入(PCI)术后生活质量及血瘀证计分的影响。方法:在我国40所医疗中心纳入2012年2月—2015年12月行PCI治疗的ACS合并T2DM病人,以是否使用冠心丹参滴丸为暴露因素,分为冠心丹参滴丸组和常规治疗组。常规治疗组根据指南推荐进行常规西药治疗,冠心丹参滴丸组在常规西药治疗基础上加用冠心丹参滴丸每次0.4 g,每日3次,疗程为12个月。以西雅图心绞痛量表(SAQ)评分及血瘀证计分为疗效评价指标,采用广义估计方程(GEE)进行统计学分析。结果:650例病人完成了随访,其中冠心丹参滴丸组340例、常规治疗组310例。与常规治疗组比较,冠心丹参滴丸组在治疗第12个月时SAQ总分增加(P<0.05),治疗第6个月、第12个月时血瘀证计分明显下降(P<0.05或P<0.01)。结论:冠心丹参滴丸可改善ACS合并T2DM病人PCI后SAQ评分,降低血瘀证计分,提高病人生活质量。
Objective:To observe the effects of Guanxin Danshen Dropping Pills on quality of life and blood stasis syndrome score in patients with acute coronary syndrome(ACS)complicated with type 2 diabetes mellitus(T2DM)after percutaneous coronary intervention(PCI).Methods:The patients with ACS combined with T2DM who underwent PCI from February 2012 to December 2015 were enrolled in 40 medical centers in China,and they were divided into Guanxin Danshen dropping pill group and conventional treatment group according to whether Guanxin Danshen dropping pill was used as exposure factor.The patients of conventional treatment group were treated with conventional western medicine as recommended by the guidelines,and the patients of the Guanxin Danshen dropping pill group were also treated with Guanxin Danshen dropping pill 0.4 g each time,3 times a day,for 12 months.Seattle Angina Pectoris Scale(SAQ)and blood stasis syndrome score were used as evaluation indexes,and generalized estimation equation(GEE)was used for statistical analysis.Results:Six hundred and fifty patients completed follow-up,including 340 patients in the Guanxin Danshen dropping pill group and 310 patients in the conventional treatment group.Compared with the conventional treatment group,the total score of SAQ in the Guanxin Danshen dropping pill group increased at the 12th month of treatment(P<0.05),and the score of blood stasis syndrome decreased significantly at the 6th and 12th months of treatment(P<0.05 or P<0.01).Conclusion:Guanxin Danshen dropping pills could improve the SAQ score,reduce the score of blood stasis syndrome,and improve the quality of life in ACS patients with T2DM after PCI.
作者
蔡雅杰
杨巧宁
于燕乔
杨芙蓉
杨严凯
崔卓睿
白瑞娜
史大卓
CAI Yajie;YANG Qiaoning;YU Yanqiao;YANG Furong;YANG Yankai;CUI Zhuorui;BAI Ruina;SHI Dazhuo(Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China)
出处
《中西医结合心脑血管病杂志》
2024年第15期2708-2712,共5页
Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金
国家中医药行业科研专项(No.201007001)
中国中医科学院西苑医院名老中医经验传承研究专项(No.XYZX0101-01)
中华中医药学会青年求实项目(No.2022-QNQSDEP-01)
中医药临床科研一体化平台建设专项(No.XYZX0405-32)。
关键词
急性冠脉综合征
2型糖尿病
经皮冠状动脉介入术
冠心丹参滴丸
西雅图心绞痛量表
血瘀证计分
acute coronary syndrome
type 2 diabetes mellitus
percutaneous coronary intervention
Guanxin Danshen dropping pills
Seattle Angina Scale
Blood Stasis Syndrome Score
作者简介
通讯作者:白瑞娜,E-mail:brntcl@126.com;通讯作者:史大卓,E-mail:Shidztcm@163.com。
